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Abstract
Background: There is a need for sensitive and specific rapid diagnostic tests (RDT) for canine visceral leishmaniasis. The aims
of this study were to evaluate the diagnostic performance of immunochromatographic dipstick RDTs using rK39 antigen for
canine visceral leishmaniasis by (i) investigating the sensitivity of RDTs to detect infection, disease and infectiousness in a
longitudinal cohort study of natural infection in Brazil, and (ii) using meta-analysis to estimate the sensitivity and specificity
of RDTs from published studies.
Methodology: We used a rK39 RDT (Kalazar Detect Canine Rapid Test; Inbios) to test sera collected from 54 sentinel dogs
exposed to natural infection in an endemic area of Brazil. Dogs were sampled bimonthly for up to 27 months, and rK39
results compared to those of crude antigen ELISA, PCR, clinical status and infectiousness to sandflies. We then searched
MEDLINE and Web of Knowledge (1993–2011) for original studies evaluating the performance of rK39 RDTs in dogs. Meta-
analysis of sensitivity and specificity was performed using bivariate mixed effects models.
Principal Findings: The sensitivity of the rK39 RDT in Brazil to detect infection, disease and infectiousness was 46%, 77%
and 78% respectively. Sensitivity increased with time since infection, antibody titre, parasite load, clinical score and
infectiousness. Sixteen studies met the inclusion criteria for meta-analysis. The combined sensitivity of rK39 RDTs was 86.7%
(95% CI: 76.9–92.8%) to detect clinical disease and 59.3% (37.9–77.6%) to detect infection. Combined specificity was 98.7%
(89.5–99.9%). Both sensitivity and specificity varied considerably between studies.
Conclusion: The diagnostic performance of rK39 RDTs is reasonable for confirmation of infection in suspected clinical cases,
but the sensitivity to detect infected dogs is too low for large-scale epidemiological studies and operational control
programmes.
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Introduction
Zoonotic visceral leishmaniasis (ZVL) is a potentially fatal
disease caused by the intracellular protozoan parasite Leishmania
infantum, which is endemic in South and Central America, the
Mediterranean basin and parts of Asia. The domestic dog is the
most important reservoir host, and infection is maintained by
transmission between dogs by phlebotomine sandfly species [1].
Control of ZVL focuses on the detection and elimination of
infected dogs (particularly in Latin America), control of vectors
and human case detection and treatment. There is little evidence
for the effectiveness of dog culling [1–3]. Treatment of infected
dogs is also not an effective control method, due to the cost and
long course of treatment, and frequent relapse [4]. Canine
treatment using human therapeuticals will also increase the risk
of drug resistance, and has been banned in some endemic
countries. The use of long-lasting insecticides, applied to dogs as
collars, spot-on formulations or baths, is a potential control
strategy; such methods have not yet been widely tested or
implemented, though are increasingly purchased commercially for
protection of individual dogs [1,2,5].
Diagnosis of ZVL is usually carried out using serological tests
based on crude or recombinant parasite antigens, or molecular
tests such as PCR, since parasitological diagnosis has low
sensitivity. Serological tests such as ELISA and DAT generally
have high sensitivity, while the sensitivity of IFAT is usually lower;
specificity of serology is more variable [2]. PCR, particularly
quantitative real-time PCR, can be more sensitive than serology,
and has high specificity [6,7]. Current guidelines for the diagnosis
of ZVL suggest the use of quantitative serology followed by PCR
PLOS Neglected Tropical Diseases | www.plosntds.org 1 January 2013 | Volume 7 | Issue 1 | e1992
[8], and this combination allows the detection of most infected
dogs. However, these tests have important drawbacks for
operational control programmes in resource-poor countries:
testing requires technical skills and adequate sample storage prior
to testing, and transport and laboratory processing leads to time
delays between sampling, diagnosis, and the application of the
control intervention. Both theoretical and empirical studies have
highlighted delays between sampling and culling, coupled with the
lack of sensitivity of some serological tests, as important factors
underlying the failure of dog culling to control infection in Brazil
[3,9]. In an operational setting, a rapid diagnostic test (RDT) with
high sensitivity that would allow for timely in situ diagnosis of
infection would thus be invaluable for large scale control of
infected dogs [2]. In a clinical setting, RDTs would be useful to
confirm diagnosis of canine leishmaniasis, as clinical signs are not
necessarily specific to ZVL. The diagnostic performances required
for these two settings are very different: for veterinarians, high
sensitivity and high specificity in the diagnosis of clinical disease is
critical, while for use in control programmes, high sensitivity to
detect infected and infectious dogs is more important.
Several RDTs have now been developed for the diagnosis of VL
in both humans and dogs. The most widely used are immuno-
chromatographic dipstick tests based on the Leishmania rK39
antigen. rK39 is a 39 amino acid repetitive immunodominant B-
cell epitope in a kinesin-related protein, which is conserved
between L. infantum and L. donovani, and provides high sensitivity to
detect clinical cases in ELISA [10,11]. Incorporation of this
antigen into a dipstick format has the major advantages of
increased ease and speed of use, with a diagnostic result indicated
within minutes without the need for specialist equipment. A
number of studies have investigated the use of rK39 RDTs for the
diagnosis of human VL, and a recent meta-analysis concluded that
rK39 RDTs had high sensitivity (93.9%) and specificity (90.6%) to
detect clinically symptomatic human cases [12]. Individual studies
on dogs using RDTs show a variable sensitivity and specificity
[13–28], with no published meta-analysis study to estimate cross-
study performance. Sensitivity has been reported to vary with
clinical status [18,22] and antibody titre [16,21], but little
information is available on other variables that potentially affect
rK39 positivity. In particular, variation in sensitivity during the
course of natural infection has not been examined: studies to date
have been mostly cross-sectional, with longitudinal data limited to
two small studies [29,30]. Moreover, research to measure the
association between rK39 RDT positivity and canine infectious-
ness to sandflies has not yet been carried out. Since infectious
rather than infected dogs are the epidemiologically important
target to reduce ZVL transmission, performance of diagnostic tests
to detect infectious dogs is a research priority [2].
The aims of the current study were (i) to evaluate the sensitivity
of a rK39 RDT to detect infection, disease and infectiousness in a
cohort of naturally-infected dogs in Brazil, (ii) to compare the
sensitivity of rK39 RDT with crude antigen ELISA, which was a
highly sensitive test in this cohort [3,31], (iii) to examine variation
in sensitivity during the course of infection, and in dogs with
varying parasite loads and antibody titres to crude parasite
antigen, and (iv) to use meta-analytical techniques to estimate the
combined sensitivity and specificity of rK39 RDTs from published
studies. The first three aims take advantage of samples from a very
well-characterized cohort of dogs in Brazil, which were sampled
bimonthly during the acquisition and development of natural
infection and infectiousness in Amazon Brazil [3,32].
Methods
Ethics statement
Canine samples were collected with informed consent from dog
owners. Sampling was performed in accordance with UK Home
Office guidelines.
Study site and study design
Serum samples were selected using archived material from a
prospective cohort study carried out from April 1993 to July 1995
in the municipality of Salvaterra, Marajo´ Island, Para´ State,
Brazil. The study design has been described previously [3,31,32].
Briefly, 126 initially uninfected dogs were placed at intervals
within households in the study site, and sampled approximately
every 2 months (mean interval 67 days, range 58–80 days) during
exposure to natural infection, for a maximum of 27 months. Of the
86 dogs that became infected during the study, we selected 322
samples from the 54 dogs with the longest periods of follow-up
after infection. Time of patent infection in study dogs was defined
using our previous results as the first time point of detection of
Leishmania infection by any of the following methods: (i) detection
of anti-Leishmania IgG by ELISA using crude leishmanial antigen
(CLA), with antibody concentrations expressed as arbitrary units/
mL relative to a positive control serum (n= 322) [31]; (ii) PCR on
bone marrow biopsies using primers specific for kinetoplast DNA
(kDNA) and ribosomal RNA (n= 196) [31]; (iii) quantitative
kDNA PCR on bone marrow biopsies, with results expressed as
parasites/mL (n = 151) [6]; (iv) rK39 ELISA, with antibody
concentrations expressed as signal/positive (s/p) ratio (n = 179)
[33], where the cut-off was calculated from the back-transformed
mean +3 SD of the log10 s/p ratios of 12 endemic control dogs. All
samples taken on or after the time of patent infection were
classified as from an infected dog. Dogs were also clinically
examined at each time point, and assigned a semi-quantitative
clinical score by scoring on a scale 0 (absent) to 3 (intense) six
typical clinical signs of leishmaniasis (alopecia, dermatitis, chan-
cres, conjunctivitis, onychogryphosis, and lymphadenopathy)
(n = 295) [31]. A proportion of dogs was also assessed for
infectiousness to the sandfly vector by xenodiagnosis, using
uninfected colony-reared Lutzomyia longipalpis (n = 122) [3].
Author Summary
Canine visceral leishmaniasis is a vector-borne disease
caused by the intracellular parasite Leishmania infantum. It
is an important veterinary disease, and dogs are also the
main animal reservoir for human infection. The disease is
widespread in the Mediterranean area, and parts of Asia
and South and Central America, and is potentially fatal in
both dogs and humans unless treated. Diagnosis of canine
infections requires serological or molecular tests. Detection
of infection in dogs is important prior to treatment, and in
epidemiological studies and control programmes, and a
sensitive and specific rapid diagnostic test would be very
useful. Rapid diagnostic tests (RDTs) have been developed,
but their diagnostic performance has been reported to be
variable. We evaluated the sensitivity of a RDT based on
serological detection of the rK39 antigen in a cohort of
naturally infected Brazilian dogs. The sensitivity of the test
to detect infection was relatively low, but increased with
time since infection and the severity of infection. We then
carried out a meta-analysis of published studies of rK39
RDTs, evaluating the sensitivity to detect disease and
infection. The results suggest that rK39 RDTs may be useful
in a veterinary clinical setting, but the sensitivity to detect
infection is too low for operational control programmes.
rK39 RDTs in Canine Visceral Leishmaniasis
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Negative control dogs comprised (i) 30 unexposed, non-endemic
UK dogs with no history of foreign travel that had attended two
UK veterinary clinics during June to December 2007, (ii) 8 non-
endemic control samples from Brazilian study dogs prior to being
placed in the endemic area, and (iii) 29 endemic control samples
from 28 Brazilian study dogs taken prior to infection.
Sample storage and quality control
Serum samples were collected during 1993–1995 and aliquotted
at the time of collection. For long-term storage, samples were kept
at 280uC. CLA ELISA was carried out in 1996, and rK39 ELISA
and RDTs in 2008. Samples had been briefly thawed up to 5 times
by the time of rK39 testing. Prior to the use of rK39 RDTs, all
samples (n = 180) tested by rK39 ELISA were also re-tested by
CLA ELISA to ensure continued sero-reactivity. A single sample
showed reduced reactivity and was removed from further analysis.
The remaining samples showed a good agreement with the results
of the initial CLA ELISA, with a strong and consistent positive
correlation between antibody concentrations in 1996 and 2008
(r2 = 0.78). 127/179 (71%) samples were seropositive in 1996 and
124/179 (69%) in 2008, with a high degree of concordance
between years (kappa= 0.83) and no significant difference in
sensitivity (McNemar’s x2 test, P = 0.41).
rK39 RDT
rK39 RDTs (Kalazar Detect Canine Rapid Test: Lot
No. HA1047 and HD1037) were obtained from Inbios Interna-
tional Inc., WA, USA, and used to test 20 mL serum samples
according to the manufacturer’s instructions. The appearance of a
red line in the test area, however faint, was interpreted as positive
following manufacturer’s recommendations; all samples tested
were classified as either positive or negative. All RDTs were
performed by the same person, who was not blind to the results of
reference tests.
Meta-analysis
Literature searches were carried out in Medline and Web of
Knowledge for articles published from 1993 to the end of 2011
using the keywords leishman* AND (canine OR dog) AND
(rK39 OR K39 OR dipstick OR immunochromato-
graphic OR ICT OR strip OR ‘rapid test’ OR ‘rapid
diagnostic test’ OR RDT OR Trald). This search produced
100 papers, for which the titles, abstracts and, if necessary, full text
were examined. Inclusion criteria for studies were (i) original
studies, published in full (not conference abstracts), (ii) studies of
natural infection with L. infantum (including L. chagasi), (iii) index
test using rK39 antigen only in a dipstick format, (iv) data
presented on the sensitivity and/or specificity of the index test, or
derivable from from the data presented, and (v) infection
confirmed by a suitable reference test (serology, parasitology or
PCR). All studies that met these criteria were included, regardless
of study design, and including both studies of diagnostic accuracy
and studies that used rK39 RDTs in other contexts, or that
reported only sensitivity data. Data were extracted on the number
of study animals, country in which the study was carried out, study
design, supplier of the dipstick test, case and control definitions
and test results (absolute numbers of true positives, false positives,
true negatives and false negatives). Where the latter numbers were
not directly reported, they were derived from the reported sample
sizes and sensitivity, specificity or prevalence. Cases were recorded
as (i) clinical cases, defined as dogs with one or more symptoms
suggestive of ZVL, and infection confirmed by one or more
diagnostic tests (serology, PCR or parasitology) (ii) asymptomatic
cases, or (iii) all infected cases, with confirmed infection
irrespective of clinical status. Controls were classified as (i) non-
endemic controls (NEC: dogs living in areas with no Leishmania
transmission), (ii) endemic controls (EC: dogs living in endemic
areas but with negative diagnostic test result for Leishmania
infection) and (iii) dogs with other diseases (OD: dogs with
confirmed disease that could potentially cross-react serologically).
Study design was recorded as case-control (separate defined groups
of cases and controls), cross-sectional (animals from a cross-
sectional survey divided into cases and controls by one or more
diagnostic tests) and cohort. Where studies compared the
performance of rK39 with other serological tests in dogs whose
status was defined by parasitology/PCR rather than serology,
results of these serological tests were also extracted in the same
way. Results from the current study were included in the meta-
analysis; to avoid inflation of the weighting of this study due to
multiple sampling of individual dogs, the estimated number of
positive dogs was calculated from the overall proportion of samples
positive and the number of dogs sampled (Table 1). Where studies
used two reference tests, cases were defined as positive in either
test, and controls as negative in both tests. Two studies used DAT
as a reference test and presented rK39 results stratified by DAT
titre [16,21]: in this case the cut-off titre was taken as 1:320, and
effects of using a different cut-off tested. One study [15] tested two
formulations of rK39 dipsticks, using protein A or protein G, with
very similar results – results for the protein A formulation only
were included in the meta-analysis.
Statistical analysis
Cohort data The proportions of dogs positive by CLA ELISA and
rK39 RDT were estimated from generalized estimating equation
logistic regression models to control for within-dog autocorrela-
tion; 95% confidence intervals were estimated using robust
standard errors. Similar models were used to test associations
between rK39 RDT results and other dog variables (i.e. time since
infection, clinical status, xenodiagnosis, CLA ELISA and PCR
results). Test sensitivities were compared using McNemar’s x2 test.
Analysis was carried out in Stata 11.1 (Stata Corporation, College
Station, Texas, USA).
Meta-analysis Sensitivity and specificity were calculated for each
study group, with Wilson 95% confidence intervals [34]. Meta-
analysis was performed using bivariate random-effects logistic
regression models, with study included as the random effect [35].
Analyses were performed in Stata 11.1, using the ‘metandi’
command, and the options ‘glamm’ and ‘force’ to include any
studies that did not provide data on either sensitivity or specificity.
Sensitivity was estimated for clinical cases, asymptomatic cases and
all infected cases (studies including both clinical and asymptomatic
cases). For an overall estimate of specificity, an additional analysis
of all studies with specificity data was performed. Publication bias
was assessed visually from plots of sensitivity and specificity in each
study against the number of cases or controls.
Results
Cross-sectional analysis
A total of 133/322 (41%) serum samples from 38/54 (70%)
Brazilian dogs tested rK39 RDT positive, while 16/54 (30%) dogs
remained rK39 RDT negative throughout the course of sampling.
By comparison, CLA ELISA gave positive results in 243/322
(75%) samples from 54/54 dogs. Using samples from dogs with
confirmed infections (see Methods), the overall sensitivity for
detection of infection by rK39 RDT was estimated as 46% (95%
CI 37–55%)(Table 1). Sensitivity was higher (77%, 95% CI 64–
86%) in symptomatic infected dogs, and there was a strong
rK39 RDTs in Canine Visceral Leishmaniasis
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association between rK39 RDT positivity and disease severity:
sensitivity increased from 33% (95% CI 24–43%) in asymptomatic
dogs, to 69% (95% CI 53–82%) in oligosymptomatic and 89%
(95% CI 70–97%) in polysymptomatic dogs (Table 1). Sensitivity
was also higher in dogs that were infectious at the time of sampling
(78%, 95% CI 59–89%) compared to non-infectious dogs (47%,
95% CI 32–62%). As previously reported, CLA ELISA was
generally a highly sensitive test in this study population [31], and
the sensitivity of CLA ELISA was significantly superior to rK39
RDT in all classes of dogs (P#0.031) except for polysymptomatic
dogs, in which sensitivity of the 2 tests did not differ significantly
(P = 0.13). All 30 UK non-endemic dogs were negative by rK39
RDT, as were all 37 samples from 36 uninfected Brazilian dogs,
giving a specificity of 100% to detect infection.
Results were available from rK39 ELISA for a subset of 179/
322 of the samples which were tested with rK39 RDT. As shown
in Figure 1, there was a strong positive association between rK39
RDT positivity and the rK39 ELISA s/p ratio: no sample with s/p
ratio ,0.77 was RDT positive, whereas 92% (60/65) of samples
above this point were RDT positive. In samples from dogs with
confirmed infections tested by both methods, the sensitivity of
rK39 RDT was 39% (60/155), lower than the sensitivity of rK39
ELISA (49%: 76/155; McNemar’s x2 = 16.0, P,0.0001). The
sensitivity of rK39 ELISA was lower than that of CLA ELISA
(83%, 128/155) in these samples, as previously reported [33].
Longitudinal analysis
rK39 RDT sensitivity increased with time since confirmed
infection to a plateau by 6 months after infection; this was slower
than the increase in CLA ELISA positivity, which reached
maximal prevalences at 2–4 months after infection (Figure 2). The
proportion of rK39 RDT positive dogs reached a maximum 2
months earlier than the proportion of symptomatic dogs (Figure 2).
The relationship between rK39 RDT positivity and time from
patent infection was highly significant and non-linear, with
significant effects of both time and time2 (both
P,0.0001)(Figure 2). There was no decline in the proportion of
dogs that were RDT positive at later time points, indicating
minimal serorecovery. This was confirmed by examination of test
results for individual dogs: of 36 dogs which tested positive by
rK39 RDT at .1 time point, only 3 (8.3%) dogs had a single
sample that tested rK39 RDT negative after rK39 seroconversion
(1/3 of which was borderline positive by CLA ELISA). In all cases
the negative rK39 RDT result was followed by a positive result in
the next sample.
RDT positivity in samples from infected dogs increased
significantly with the log10 CLA ELISA titre, reaching 100% in
dogs with the highest antibody concentrations (Table 2;
Figure 3). Seropositivity in both CLA ELISA and rK39 RDT
increased significantly with bone marrow parasite load, assessed
by quantitative kDNA PCR, but rK39 RDT positivity only
reached 72% even in dogs with the highest parasite loads
(Table 2; Figure 4). The odds of being rK39 RDT positive were
significantly higher in samples from dogs that were symptomatic
(OR= 1.97, 95% CI 1.10–3.51), PCR positive (OR= 5.99, 95%
CI 2.34–15.3) or infectious to sandflies (OR= 3.68, 95% CI
1.87–7.24) (Table 2). When adjusting analysis to include all
explanatory variables, only high CLA ELISA titre and
increasing time since infection remained as significant predictors
of a positive rK39 RDT. Similar associations were seen between
dog infection variables and rK39 ELISA results (data not
shown).
Table 1. Sensitivity of rK39 RDT and CLA ELISA in samples from infected and uninfected dogs.
n (N) CLA ELISA rK39 RDT
% (95% CI) % (95% CI)
Infected dogs 285 (54) 85.3 (80.4–89.1) 45.6 (36.8–54.7)
Uninfected endemic dogs 29 (28) - 0
Brazil non-endemic dogs 8 (8) - 0
UK non-endemic dogs 30 (30) - 0
Infected dogs by serological status1
- seropositive 243 (54) - 52.2 (42.1–62.0)
- seronegative 42 (32) - 0
Infected dogs by PCR status
- PCR positive 111 (45) 91.8 (85.0–95.6) 58.6 (47.8–68.7)
- PCR negative 74 (30) 67.7 (53.5–79.3) 26.3 (14.7–42.6)
Infected dogs by clinical status
- Symptomatic 99 (39) 95.3 (83.9–98.8) 76.5 (63.8–85.7)
- Polysymptomatic 39 (25) 97.4 (82.6–99.7) 88.9 (70.2–96.5)
- Oligosymptomatic 60 (30) 93.4 (79.7–98.1) 69.1 (52.5–81.9)
- Asymptomatic 178 (51) 81.3 (75.0–86.4) 32.6 (23.9–42.7)
Infected dogs by xenodiagnosis
- Infectious 35 (18) 100 77.7 (59.0–89.4)
- Non-infectious 81 (27) 80.6 (69.0–88.5) 46.6 (32.0–61.8)
The percentage of dogs positive (95% CI) by each test for different classes of dogs was estimated using general estimating equations with robust standard errors, to
account for the non-independence of repeat samples from the same dog. n – number of samples; N – number of dogs.
1as defined by CLA ELISA.
doi:10.1371/journal.pntd.0001992.t001
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Meta-analysis
The literature search retrieved 31 studies reporting the use of
rK39 RDTs (dipsticks) in dogs, of which 16 original studies, plus
the current study, reported data on the sensitivity of rK39 RDTs
to detect canine infection (Figure 5). Eleven of these studies also
included data on specificity. Of the 17 studies, 9 were carried out
in the New World and 8 in the Old World; studies included 526
dogs with clinical disease (from 12 studies), 299 dogs with
asymptomatic infection (from 7 studies), 431 dogs with confirmed
infection (from 10 studies which included both clinical and
asymptomatic dogs) and 1411 uninfected controls (from 11
studies). Twelve studies reported sensitivity in symptomatic
Figure 1. rK39 ELISA results in Brazilian dogs that tested positive or negative by rK39 RDT. rK39 ELISA results expressed as signal/positive
(s/p) ratio. Dashed line indicates the rK39 ELISA cut-off.
doi:10.1371/journal.pntd.0001992.g001
Figure 2. Sensitivity of CLA ELISA and rK39 RDT, and the proportion of symptomatic dogs, through time. Samples (n = 285) were
aligned by time from first detection of infection. Key: CLA ELISA (open circles); rK39 RDT (closed circles); symptomatics (triangles). Each point
represents 15–50 dogs.
doi:10.1371/journal.pntd.0001992.g002
rK39 RDTs in Canine Visceral Leishmaniasis
PLOS Neglected Tropical Diseases | www.plosntds.org 5 January 2013 | Volume 7 | Issue 1 | e1992
infected dogs, selected on the basis of one or more clinical signs
(Table 3). The estimated combined sensitivity in symptomatic dogs
was 86.7% (95% CI 76.9–92.8%). Sensitivity varied from 50–
100% in individual studies: sensitivity was high (85–97%) in 5
case-control studies, but lower in most cross-sectional studies. If a
higher cut-off of 1:640 was used for the one study with DAT as a
reference test [16], the combined rK39 RDT sensitivity for
symptomatics across all studies increased to 89.6% (95% CI 79.5–
95.0%).
In contrast, the sensitivity of rK39 RDTs to detect asymptom-
atic infection was low, with a combined sensitivity of 49.7% (95%
CI 29.3–70.1%) across 7 studies (Table 4). The sensitivity to detect
all infected dogs irrespective of clinical status was slightly higher,
59.3% (95% CI 37.9–77.6%), though these results are not directly
comparable due to the somewhat different sets of studies in each
analysis (Table 5). Using a higher DAT cut-off in one study [21]
increased the overall sensitivity of rK39 RDT to detect infected
dogs to 63.9% (95% CI 42.0–81.2%). Sensitivity to detect
asymptomatic or infected dogs was highly variable between
studies.
Considering all meta-analyses, there were no clear geographical
differences in sensitivity between studies, though one Chinese
study reported notably low sensitivity [28]. An additional study of
L. donovani infection (thus not included in the meta-analysis)
reported a low sensitivity (31%) of rK39 RDT to detect infection
in Ethiopian dogs [36]. Of the 17 studies, 8 used tests obtained
from Inbios International Inc, and 6 used tests distributed by
Cypress Diagnostic Company, Intersep or Diasys Europe Ltd that
were presumed to be tests manufactured by Inbios. Only one study
used a test from a different manufacturer, Diamed AG [18], while
two studies did not provide manufacturer details [13,26].
Comparisons between tests from different manufacturers were
thus not possible. In studies that directly compared the sensitivity
of rK39 RDTs with crude antigen ELISA or IFAT, ELISA was
more sensitive in all comparisons, while sensitivity of IFAT was
comparable to that of dipsticks (Tables 3, 4, 5). Only one study
reported a higher sensitivity of rK39 RDT (42%) compared to
both ELISA (12%) and IFAT (18%) [37]; data from this study
were not presented in a suitable format for inclusion in the meta-
analysis. Studies used a variety of reference tests to confirm
infection (Tables 3, 4, 5). Generally higher sensitivities were
reported by the few studies that used parasitological confirmation
(examination of smears or culture), compared to serology or PCR
as a reference test.
The estimated combined specificity of rK39 RDTs was 98.7%
(95% CI 89.5–99.9%). There was high specificity (93–100%) in 8/
Figure 3. Proportion of dogs positive by rK39 RDT according to anti-CLA IgG concentrations. IgG concentrations expressed as arbitrary
units/mL relative to positive control serum, by ELISA. Each point represents 31–32 samples. Dashed line indicates the CLA ELISA cut-off.
doi:10.1371/journal.pntd.0001992.g003
Table 2. Factors associated with a positive rK39 RDT result in
samples from infected Brazilian dogs.
Variable Odds Ratio (95% CI) P
PCR status: negative 1
positive 5.99 (2.34–15.3) 0.0002
Clinical status: asymptomatic 1
oligosymptomatic 1.47 (0.77–2.80)
polysymptomatic 3.47 (1.47–8.17) 0.015
Clinical status: asymptomatic 1
symptomatic 1.97 (1.10–3.51) 0.022
Infectious: no 1
yes 3.68 (1.87–7.24) 0.0002
CLA ELISA titre (per 106 increase) 20.2 (8.52–48.0) ,0.0001
Parasite burden (per 106 increase) 1.64 (1.22–2.20) 0.001
Odds Ratios (95% CI) were estimated using general estimating equations with
robust standard errors, to account for the non-independence of repeat samples
from the same dog. All analyses included time since confirmed infection
(months and months2) as covariates.
doi:10.1371/journal.pntd.0001992.t002
rK39 RDTs in Canine Visceral Leishmaniasis
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Figure 5. Flow diagram for study inclusion in meta-analysis.
doi:10.1371/journal.pntd.0001992.g005
Figure 4. Proportion of infected dogs positive by CLA ELISA and rK39 RDT according to parasite density in bone marrow. Parasite
density expressed as number of parasites/mL of bone marrow biopsy by quantitative kDNA PCR. Key: CLA ELISA (open circles); rK39 RDT (closed
circles). Each point represents 25 samples.
doi:10.1371/journal.pntd.0001992.g004
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11 studies, but much lower specificity (65–85%) in 3 studies
(Table 6). This variation did not appear to be related to the type of
control used, but seemed to be study-specific. Specificity using
groups of dogs with other confirmed infections was comparable to
that using endemic and non-endemic control dogs (Table 7).
Cross-reactions using RDTs were tested in few studies, but
included dogs infected with Ehrlichia canis (1 of 3 dogs), Trypanosoma
cruzi (3/12) and Neospora caninum (1/9) [18,22]. There was no
evidence for publication bias in either sensitivity or specificity.
Discussion
The present study is the most detailed study to date of the
factors affecting rK39 RDT positivity in dogs. The overall
sensitivity of the rK39 RDT in all samples from infected dogs in
the Brazil cohort was low (46%). Sensitivity to detect symptomatic
dogs was higher (77%). Previous studies employing the rK39
antigen have also shown an association between rK39 positive test
results and presence of active clinical disease in both humans [11]
and in dogs [18,22,38–40]. Our results show that antibody
responses to rK39 in natural infection develop more slowly than
responses to crude antigen: dipstick sensitivity was particularly low
in the early stages of infection and increased to a maximum 6–8
months after patent infection. Anti-rK39 responses developed
before the peak of clinical infection, as also observed in
experimental infection [30]. A positive RDT result was strongly
associated with severe infection, being positively correlated with
markers of disease progression, including parasite load, anti-
Leishmania antibody level and time since infection. However, the
proportion of RDT positive dogs did not reach 100% even in
polysymptomatic dogs and dogs with the highest parasite loads
(most likely to be responsible for the majority of transmission). The
strongest association was between rK39 positivity and antibody
titre, as reported in other studies [16,21]. Infectiousness to
sandflies is also a characteristic of dogs with severe disease [3].
The sensitivity of rK39 RDTs to detect infectious dogs has not
Table 3. Estimates of the sensitivity of rK39 RDTs to detect symptomatic visceral leishmaniasis in dogs.
Country Study design1 Supplier2 Reference test Number of cases rK39 RDT % (95% CI) ELISA4 % IFAT % Ref.
Brazil CC Inbios IFAT 50 96.0 (86.5–98.9) - - [15]
Iran XS Cypress DAT 126 73.8 (65.5–80.7) - - [16]
Turkey XS Inbios Smear or IFAT 12 100 (75.8–100) - - [17]
Mediterranean CC Diamed Culture or PCR 30 96.7 (83.3–99.4) 100 90 [18]
Italy CC Intersep Smear 68 97.1 (89.9–99.2) - 98.5 [19]
Turkey XS Intersep ELISA 8 87.5 (52.9–97.8) - 100 [20]
Brazil CC Inbios Smear 60 85.0 (73.9–91.9) 95 - [22]
Brazil XS Inbios ELISA 38 57.9 (42.2–72.1) - - [23]
Argentina XS Inbios PCR 42 66.7 (51.6–79.0) - 66.7 [25]
Brazil CC -3 PCR 47 91.5 (80.1–96.6) 100 - [26]
China XS Inbios PCR 6 50.0 (18.8–81.2) 83.3 - [28]
Brazil Cohort Inbios PCR or ELISA 39 76.9 (61.7–87.4) 95 - this study
Combined 86.7 (76.9–92.8)
1CC – case-control; XS – cross-sectional;
2Inbios International Inc, WA, USA; Cypress Diagnostic Company, Belgium; Intersep DiaSys Europe Ltd; Diamed AG, Switzerland;
3not stated;
4crude antigen.
doi:10.1371/journal.pntd.0001992.t003
Table 4. Estimates of the sensitivity of rK39 RDTs to detect asymptomatic Leishmania infantum infection in dogs.
Country Study design1 Supplier2 Reference test Number of dogs rK39 RDT % (95% CI) ELISA4 % IFAT % Ref.
Mediterranean CC Diamed Culture or PCR 17 52.9 (31.0–73.8) 100 29 [18]
Turkey XS Intersep ELISA 7 85.7 (48.7–97.4) - 100 [20]
Brazil CC Inbios Smear 16 75.0 (50.5–89.8) 94 - [22]
Italy XS3 Intersep ELISA 143 55.9 (47.8–63.8) - 59 [24]
Argentina XS Inbios PCR 9 55.6 (26.7–81.1) - 60 [25]
China XS Inbios PCR or ELISA 56 10.7 (5.0–21.5) 61 - [28]
Brazil Cohort Inbios PCR or ELISA 51 33.3 (22.0–47.0) 81 - this study
Combined 49.7 (29.3–70.1)
1CC – case-control; XS – cross-sectional;
2Inbios International Inc, WA, USA; Cypress Diagnostic Company, Belgium; Intersep DiaSys Europe Ltd; Diamed AG, Switzerland;
3data from first time-point of a cohort study;
4crude antigen.
doi:10.1371/journal.pntd.0001992.t004
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previously been reported; here we found that infectious dogs (by
xenodiagnosis) were more likely to be RDT positive, which is not
unexpected given the associations between infectiousness, clinical
symptoms and antibody concentrations [1,3]. For intervention
programmes, high sensitivity to detect infectious dogs is needed;
ideally, tests would also be able to discriminate between infectious
and non-infectious dogs, enabling the possibility of targeted
control. However, the sensitivity of rK39 RDTs to detect
infectious animals was only 78%, which is likely to be too low
for an effective intervention programme [3].
Meta-analysis of published data, including data from the current
study, suggests that rK39 RDTs provide a reasonably sensitive and
specific test for infection in dogs with clinical symptoms. The
overall sensitivity and specificity using a random-effects model
were 87% (95% CI 77–93%) and 99% (95% CI 90–100%). The
rK39 RDT sensitivity was slightly lower than the sensitivity (94%)
in human clinical infection with L. donovani or L. infantum
worldwide [12], but within the range reported for human L.
infantum infection in Brazil (85–92%) [41]. Both the sensitivity and
specificity varied across studies. The reasons for this variability are
unknown, and numbers of studies are too small for a detailed
comparison of different tests and geographical areas. Direct
comparisons of the performance of different RDTs on the same
samples are not available for canine infection; a recent multi-
centre comparison of two rK39 RDTs on human samples
suggested slight differences in performance [41]. Some geograph-
ical variation in RDT sensitivity for diagnosis of human VL has
been reported, with highest sensitivity for L. donovani infections in
Table 5. Estimates of the sensitivity of rK39 RDTs to detect Leishmania infantum infection in dogs.
Country Study design1 Supplier2 Reference test Number of dogs rK39 RDT % (95% CI) ELISA4 % IFAT % Ref.
China XS Corixa Smear 3 100 (43.9–100) - - [13]
Brazil XS Intersep PCR or ELISA 74 71.6 (60.5–80.6) - - [14]
Mediterranean CC Diamed Culture or PCR 47 80.9 (67.5–89.6) 100 68 [18]
Turkey XS Intersep ELISA 15 86.7 (62.1–96.3) - 100 [20]
Iran XS Cypress DAT 26 38.5 (22.4–57.5) - - [21]
Brazil CC Inbios Smear 76 82.9 (72.9–89.7) 95 - [22]
Argentina XS Inbios PCR 51 64.7 (51.0–76.4) - 65.4 [25]
Brazil XS3 Inbios IFAT 23 13.0 (4.5–32.1) - - [27]
China XS Inbios PCR or ELISA 62 14.5 (7.8–25.3) 59 - [28]
Brazil Cohort Inbios PCR or ELISA 54 46.3 (33.7–59.4) 85 - this study
Combined 59.3 (37.9–77.6)
1CC – case-control; XS – cross-sectional;
2Inbios International Inc, WA, USA; Corixa, USA; Cypress Diagnostic Company, Belgium; Intersep DiaSys Europe Ltd; Diamed AG, Switzerland;
3data from first time-point of a cohort study;
4crude antigen.
doi:10.1371/journal.pntd.0001992.t005
Table 6. Estimates of the specificity of rK39 RDTs in dogs.
Country Study design1 Supplier2 Reference test Number and type of controls3 Specificity % (95% CI) Ref.
Brazil XS Intersep PCR/ELISA 40 NEC, 101 EC 65.2 (57.1–72.6) [14]
Brazil CC Inbios IFAT 50 NEC, 14 OD 100 (94.3–100) [15]
Iran XS Cypress DAT 152 EC 84.9 (78.3–89.7) [16]
Turkey XS Inbios Smear/IFAT 10 EC6 100 (72.2–100) [17]
Mediterranean CC Diamed -5 50 NEC, 26 OD 94.7 (87.2–97.9) [18]
Italy CC Intersep Smear 22 NEC, 33 EC, 42 OD 100 (96.2–100) [19]
Brazil CC Inbios Smear/ELISA 33 NEC, 25 OD 93.1 (83.6–97.3) [22]
Brazil XS Inbios ELISA 9 EC6 77.8 (45.3–93.7) [23]
Italy XS4 Intersep ELISA 694 EC 100 (99.4–100) [24]
China XS Inbios PCR/ELISA 44 EC 97.7 (88.2–99.6) [28]
Brazil Cohort Inbios PCR/ELISA 38 NEC, 28 EC 100 (94.5–100) this study
Combined 98.7 (89.5–99.9)
1CC – case-control; XS – cross-sectional;
2Inbios International Inc, WA, USA; Cypress Diagnostic Company, Belgium; Intersep DiaSys Europe Ltd; Diamed AG, Switzerland;
3NEC non-endemic controls, EC endemic controls, OD other diseases;
4data from first time-point of a cohort study;
5not stated;
6clinically suspect dogs.
doi:10.1371/journal.pntd.0001992.t006
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the Indian subcontinent, and lower sensitivity in East Africa
[41,42], but geographical variation in sensitivity for human L.
infantum infection has not been examined. Other possible
explanations for the variation in sensitivity between canine studies
include differences in the average severity of clinical signs, study-
specific differences (e.g. in the methods to measure and define
symptoms), and differences in the specificity of clinical diagnosis
between regions. The specificity of clinical diagnosis is likely to be
higher in Europe, compared to areas with a higher prevalence of
other infections with similar symptoms. In addition, there was a
trend towards higher sensitivity in studies that used parasitology
(smears or culture) to confirm infection, which may reflect higher
parasite burdens in these dogs compared to dogs positive by
serology or PCR. The variability seen across studies highlights the
need to develop standardized protocols for diagnostic tests in
canine leishmaniasis, including standardized definitions of clinical
severity (e.g. [8]), to perform differential diagnosis, and to carry
out multi-centre trials of existing and novel tests.
Diagnostic tests using defined antigens typically have higher
specificity than those using crude antigens, due to the lower cross-
reactivity with other pathogens likely to be co-circulating in
endemic areas affected by ZVL. The overall specificity of rK39
RDTs in dogs was indeed very high (99%), slightly higher than
that reported in humans [12,41]. However, 3 of 11 studies
reported much lower specificities of 65–85% [14,16,23]. Specific-
ity might be expected to be highest in healthy non-endemic
controls, compared to healthy endemic controls (a proportion of
which may have unapparent infection) or controls infected with
other diseases (which may have cross-reacting antibodies).
However, specificity in this analysis did not vary greatly according
to the type of negative control, and most variation was seen within
rather than between types of controls. Specificity in dogs with
other diseases was not lower than in other groups of controls, as
also reported for rK39 RDTs in humans [12]. A few false positive
rK39 RDT results were reported in dogs with Ehrlichia canis,
Trypanosoma cruzi or Neospora caninum infection [18,22], though few
studies tested dogs with potentially cross-reacting infections. rK39
is restricted to species of the visceralizing L. donovani complex [10],
but cross-reactions have been reported using rK39 ELISA in 3/9
dogs infected with L. braziliensis [40], and using the rk39 RDT in
two Iranian dogs infected with L. tropica [43,44]. More extensive
characterization of rK39 antigen specificity is required before
recommendations can be made for the use of these tests in areas
with such co-circulating pathogens.
In contrast to the high sensitivity of rK39 RDTs for clinical
disease, the sensitivity to detect canine infection is much lower. The
combined sensitivity to detect infection was only 59%, attributable
to the low sensitivity to detect asymptomatic infection (50%),
though variation in sensitivity between individual studies was high.
The implications of the low overall sensitivity to detect infection
are that rK39 RDTs are not an effective tool for estimating the
prevalence of infection in epidemiological studies, nor for the
identification of infected dogs in control programmes. In studies
that directly compared the sensitivity of rK39 RDTs to crude
antigen ELISA or IFAT to detect infection, the sensitivity of
ELISA was generally higher while that of IFAT was low and
similar to the RDT. The low sensitivity of rK39 RDTs to detect
infection could be attributable to use of a single defined antigen,
and/or to the dipstick format. In the current study, the sensitivity
of rK39 ELISA was somewhat higher than rK39 RDTs, but much
lower than that of CLA ELISA. Similarly, in a European study the
sensitivity of CLA ELISA (100%) was much higher than either
rK39 ELISA (83%) or rK39 RDT (81%) [18]. These results
suggest that low sensitivity to detect asymptomatic infection is
largely due to the use of a single defined antigen. The use of
multiple defined antigens in ELISA has been shown to increase
sensitivity, with the relative sensitivity of different antigens varying
between dogs [39,40,45–47]. Thus the development of RDTs
using multiple defined antigens, or crude antigens, may increase
sensitivity [48,49]. Nonetheless, recent tests of a RDT incorpo-
rating both rK26 and rK39 reported low sensitivity (47%) to detect
asymptomatic canine infections [49].
In a veterinary clinical setting, the high specificity of rK39
RDTs indicates that they are a useful rapid test for diagnosis of
clinically symptomatic cases of canine leishmaniasis, which
currently is a diagnostic challenge as the clinical signs are not
necessarily specific. However, additional diagnostic tests are
needed for confirmation [8], particularly in clinically suspect,
rK39 dipstick-negative animals, given the potential for false
negative RDT results. In contrast, the sensitivity of rK39 RDTs to
detect infected or infectious dogs is too low for their effective use in
epidemiological studies or operational control programmes. The
rapid availability of results from on-site dipstick testing compared
to centralized laboratory serological tests is clearly desirable, as this
would prevent the long delays between sampling and diagnosis
which have been identified as an important reason for failure of
dog culling to reduce human ZVL incidence in Brazil [3]. There
may also be significant improvements in owner compliance when
presented with an unequivocal, visually interpretable result at the
time of testing. Further research is needed to develop more
sensitive RDTs, using combinations of antigens.
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Reference Non-endemic (NEC) Endemic (EC) Other diseases (OD)
[14] 75.0 61.4 -
[15] 100 - 100
[16] - 84.8 -
[17] - 100 -
[18] 94.0 - 96.2
[19] 100 100 100
[22] 100 - 84.0
[23] - 77.8 -
[24] - 100 -
[28] - 97.7 -
This study 100 100 -
doi:10.1371/journal.pntd.0001992.t007
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